Successful Launch: Virtual CV Molecular Imaging Course
Last week, ASNC launched an initiative that I firmly believe is the foundation for our field's future— personalized imaging to guide precision medicine.
- Peter Libby, MD, of Brigham and Women's Hospital and Harvard Medical School;
- James Thackeray, PhD, from Hannover Medical School (MHH);
- Pamela Woodard, MD, of Washington University in St. Louis; and
- The laboratory of Nehal Mehta, MD, MSCE, of the NIH-NHLBI.
Each of these investigators generously gave today's young investigators a thorough briefing on the work they are doing and answered questions, but more importantly, they offered a window into the future. The four presentations illustrated the unique approaches the investigators have used to study the fundamental biology of atherosclerosis, including how to identify potential imaging targets, develop a novel receptor targeted tracer for atherosclerosis, apply systems biology, and employ deep phenotyping to advance our understanding of atherosclerosis. If these leaders and research trainees inspired even one participant to similarly pursue his or her own research questions using innovative approaches or to seek out an opportunity for inter-laboratory collaboration, then this program will have succeeded and furthered ASNC's mission.
Please join us for the seven Virtual CV Molecular Imaging Seminars that ASNC will offer in the next few weeks. The next seminar will be held Tuesday, May 19, from 11:00 AM to 12:00 PM (U.S. EDT) and will feature Albert Sinusas, MD, and laboratory trainees of Mehran Sadeghi, MD, of Yale University School of Medicine, presenting on “New Technologies in Nuclear Cardiology.”
I hope you will REGISTER NOW so you don't miss this wonderful opportunity.